03:20 PM EST, 11/18/2025 (MT Newswires) -- Health care stocks rose late Tuesday afternoon, with the NYSE Health Care Index up 0.5% and the Health Care Select Sector SPDR Fund (XLV) adding 0.7%.

The iShares Biotechnology ETF (IBB) increased 0.9%.

In corporate news, AbbVie ( ABBV ) shares added 0.3% after it said the US Food and Drug Administration approved Epkinly in combination with rituximab and lenalidomide for adults with relapsed or refractory follicular lymphoma after at least one prior treatment.